Aurinia Pharmaceuticals (NASDAQ:AUPH) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Aurinia Pharmaceuticals to report an earnings per share (EPS) of $0.21.
The announcement from Aurinia Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings History Snapshot
Last quarter the company beat EPS by $0.07, which was followed by a 1.26% increase in the share price the next day.
Here’s a look at Aurinia Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.16 | 0.16 | 0.10 | -0.02 |
| EPS Actual | 0.23 | 0.16 | 0.16 | 0.01 |
| Price Change % | 1.26 | 13.47 | -3.69 | 5.30 |
Aurinia Pharmaceuticals Share Price Analysis
Shares of Aurinia Pharmaceuticals were trading at $14.59 as of February 24. Over the last 52-week period, shares are up 93.05%. Given that these …